Is a complete BCBA/AMGN research report available?

No complete published report is available for bcba/AMGN (BCBA/AMGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bcba/AMGN stock profile: metrics, valuation and analysis

Market cap	312.7T
Revenue (ttm)	56.4T
Net income (ttm)	13T
EPS (ttm)	ARS 23,844
P/E (trailing)	24.1x
P/E (forward)	16.2x
Dividend	ARS 351 (1.74%)
Volume	1,446
Beta	0.43

All BCBA/AMGN indicators

Market & fundamental data

Available fields

234

Groups with data

Currency

USD

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	31,500
Employees Change	1,300%
Employees Change Percent	4.87
Enterprise value	ARS 378.3T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-09-12
Market cap	ARS 312.7T
Price	ARS 20,140
Price currency	ARS
Rev Per Employee	1,791,674,365.08x
Sector	Healthcare
Sic	2836
Symbol	bcba/AMGN
Website	https://www.amgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.14%
EV Earnings	29.2x
EV/EBIT	19.65x
EV/EBITDA	14.27x
EV/FCF	25.09x
EV/Sales	6.56x
FCF yield	4.82%
Forward P/E	16.21x
P/B ratio	18.06x
P/E ratio	24.15x
P/S ratio	5.54x
PE Ratio10 Y	25.24x
PE Ratio3 Y	29.44x
PE Ratio5 Y	25.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	33.4%
EBITDA Margin	45.33%
FCF margin	26.18%
Gross margin	71.89%
Gross Profit	ARS 40.6T
Gross Profit Growth	13.09%
Gross Profit Growth Q	12.23%
Gross Profit Growth3 Y	11.58%
Gross Profit Growth5 Y	7.36%
Net Income	ARS 13T
Net Income Growth	32.09%
Net Income Growth Q	65.85%
Net Income Growth Qo Q	30.57%
Net Income Growth3 Y	3.09%
Net Income Growth5 Y	8.76%
Pretax Margin	27%
Profit Margin	22.95%
Profit Per Employee	ARS 411.2M
ROA	8.67
Roa5y	8.22
ROCE	18.14
ROE	91.47
Roe5y	101.8
ROIC	19.76
Roic5y	20.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	56.26%
Cagr3y	49.68%
Cagr5y	75.58%
Div CAGR10	78.98%
Div CAGR3	102.23%
Div CAGR5	94.17%
EPS Growth	31.6
EPS Growth Q	64.91
EPS Growth Qo Q	30.84
EPS Growth3 Y	2.72
EPS Growth5 Y	10.3
FCF Growth	-4.06%
FCF Growth Q	82.58%
FCF Growth Qo Q	136.22%
FCF Growth3 Y	1.66%
FCF Growth5 Y	2.72%
OCF Growth	3.87%
OCF Growth Q	75.53%
OCF Growth Qo Q	82.82%
OCF Growth10 Y	2.7%
OCF Growth3 Y	4.93%
OCF Growth5 Y	5.48%
Revenue Growth	9.1x
Revenue Growth Q	9.53x
Revenue Growth Qo Q	16.66x
Revenue Growth3 Y	12.74x
Revenue Growth5 Y	8.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.42
Assets	ARS 141.7T
Cash	ARS 20.7T
Current Assets	ARS 52.9T
Current Liabilities	ARS 38.6T
Debt	ARS 84.9T
Debt EBITDA	ARS 3.27
Debt Equity	ARS 4.9
Debt FCF	ARS 5.63
Equity	ARS 17.3T
Interest Coverage	4.14
Liabilities	ARS 124.4T
Long Term Assets	ARS 88.8T
Long Term Liabilities	ARS 85.8T
Net Cash	ARS -64.2T
Net Cash By Market Cap	ARS -20.52
Net Debt EBITDA	ARS 2.51
Net Debt Equity	ARS 3.71
Net Debt FCF	ARS 4.26
Tangible Book Value	ARS -40.7T
Tangible Book Value Per Share	ARS -75,273
WACC	6.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.37
Inventory Turnover	1.67
Net Working Capital	ARS 1.4T
Quick ratio	0.95
Working Capital	ARS 14T
Working Capital Turnover	ARS 7,182

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.46%
Dividend Growth	53.31%
Dividend Growth Years	14%
Dividend per share	ARS 351
Dividend Years	16
Dividend Yield	1.74%
Ex Div Date	2026-08-21
Last Dividend	ARS 126
Payout Frequency	Quarterly
Payout Ratio	1.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	56.21%
200-day SMA	18,195.6
3Y total return	235.41%
50-day SMA	21,084.2
50-day SMA vs 200-day SMA	50over200
5Y total return	1,567.96%
All Time High	23,810
All Time High Change	-14.49%
All Time High Date	2026-08-25
All Time Low	273.7
All Time Low Change	7,339.7%
All Time Low Date	2019-07-31
ATR	573.9
Beta	0.43
Ch YTD	22.14
High	20,450
High52	23,810
High52 Date	2026-08-25
High52ch	-15.41%
Low	20,090
Low52	12,320
Low52 Date	2025-10-27
Low52ch	63.47%
Ma50ch	-3.43%
Price vs 200-day SMA	11.9%
RSI	32.87
RSI Monthly	64.07
RSI Weekly	53.9
Sharpe ratio	1.32x
Sharpe Ratio3y	1.26x
Sharpe Ratio5y	1.54x
Sortino ratio	2.11
Sortino Ratio3y	2.04
Sortino Ratio5y	2.49
Total Return	1.27%
Tr YTD	23.9
Tr1m	-6.69%
Tr1w	-11.82%
Tr3m	20.57%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	539,159,941%
Net Borrowing	1,990,936,820,400
Shares Insiders	0.17%
Shares Institutions	83.87%
Shares Qo Q	0%
Shares Yo Y	0.46%
Short Ratio	4.76

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 14.3T
Adjusted OCF	17,757,259,000,000
Average Volume	4,055.6x
Bv Per Share	32,030.7
CAPEX	ARS -3.4T
Ch1m	-7.2
Ch1w	-11.82
Ch1y	53.31
Ch3m	19.91
Ch3y	218.7
Ch5y	1,452.4
Ch6m	11.44
Change	-1.08%
Change From Open	-1.52
Close	20,360
Days Gap	0.44
Depreciation Amortization	6,867,749,411,600
Dollar Volume	29,122,440
Earnings Date	2026-11-05
EBIT	ARS 18.9T
EBITDA	ARS 25.6T
EPS	ARS 23,844
F Score	8
FCF	ARS 15.1T
FCF EV Yield	3.99x
Financing CF	-6,111,187,500,000
Fiscal Year End	December
Founded	1,980
Goodwill	28,220,811,361,600
Graham Number	4624.62495
Graham Upside	-77.29
Income Tax	ARS 2.3T
Investing CF	-3,543,748,000,000
Is Primary Listing	0
Last Earnings Date	2026-08-04
Last Report Date	2026-06-30
Last Split Date	2024-01-24
Last Split Type	Forward
Lynch Fair Value	ARS 7,385
Lynch Upside	-63.73
Ma150	18,638.3
Ma150ch	9.24%
Ma20	22,611.5
Ma20ch	-9.96%
Net CF	8,831,221,500,000
Next Earnings Date	2026-11-05
Open	20,450
P FCF Ratio	20.75
P FCF Ratio SBC	21.8
P OCF Ratio	16.92
P OCF Ratio SBC	17.61
Payment Date	2026-09-11
Position In Range	13.89
Ppne	12,920,681,096,400
Price Date	2026-09-11
Price EBITDA	ARS 12.23
Relative Volume	0.36x
Revenue	56,437,742,500,000x
SBC By Revenue	1.29x
Share Based Comp	728,898,000,000
Tax By Revenue	4.05x
Tax Rate	15.01%
Tr6m	12.57%
Volume	1,446
Z Score	1.89

BCBA/AMGN (BCBA/AMGN)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/AMGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/AMGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BCBA/AMGN

Frequently asked questions